nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2B6—Tamoxifen—pancreatic cancer	0.0822	0.219	CbGbCtD
Tramadol—CYP2B6—Irinotecan—pancreatic cancer	0.0631	0.168	CbGbCtD
Tramadol—CYP2D6—Tamoxifen—pancreatic cancer	0.0397	0.106	CbGbCtD
Tramadol—CYP2B6—Doxorubicin—pancreatic cancer	0.0345	0.092	CbGbCtD
Tramadol—CYP2D6—Erlotinib—pancreatic cancer	0.0338	0.0901	CbGbCtD
Tramadol—CYP3A4—Tamoxifen—pancreatic cancer	0.0252	0.0673	CbGbCtD
Tramadol—CYP3A4—Erlotinib—pancreatic cancer	0.0215	0.0573	CbGbCtD
Tramadol—CYP3A4—Irinotecan—pancreatic cancer	0.0194	0.0517	CbGbCtD
Tramadol—CYP2D6—Doxorubicin—pancreatic cancer	0.0167	0.0444	CbGbCtD
Tramadol—CYP3A4—Docetaxel—pancreatic cancer	0.0142	0.0379	CbGbCtD
Tramadol—CYP3A4—Sunitinib—pancreatic cancer	0.0141	0.0377	CbGbCtD
Tramadol—CYP3A4—Doxorubicin—pancreatic cancer	0.0106	0.0283	CbGbCtD
Tramadol—Confusional state—Docetaxel—pancreatic cancer	0.00013	0.000276	CcSEcCtD
Tramadol—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000129	0.000274	CcSEcCtD
Tramadol—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000129	0.000273	CcSEcCtD
Tramadol—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000129	0.000273	CcSEcCtD
Tramadol—Epistaxis—Epirubicin—pancreatic cancer	0.000129	0.000273	CcSEcCtD
Tramadol—Pruritus—Gemcitabine—pancreatic cancer	0.000129	0.000273	CcSEcCtD
Tramadol—Infection—Docetaxel—pancreatic cancer	0.000128	0.000272	CcSEcCtD
Tramadol—Weight decreased—Doxorubicin—pancreatic cancer	0.000128	0.000271	CcSEcCtD
Tramadol—Sinusitis—Epirubicin—pancreatic cancer	0.000128	0.000271	CcSEcCtD
Tramadol—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000128	0.000271	CcSEcCtD
Tramadol—Diarrhoea—Irinotecan—pancreatic cancer	0.000128	0.000271	CcSEcCtD
Tramadol—Pneumonia—Doxorubicin—pancreatic cancer	0.000127	0.000269	CcSEcCtD
Tramadol—Shock—Docetaxel—pancreatic cancer	0.000127	0.000269	CcSEcCtD
Tramadol—Nervous system disorder—Docetaxel—pancreatic cancer	0.000127	0.000268	CcSEcCtD
Tramadol—Pruritus—Fluorouracil—pancreatic cancer	0.000127	0.000268	CcSEcCtD
Tramadol—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000126	0.000268	CcSEcCtD
Tramadol—Infestation—Doxorubicin—pancreatic cancer	0.000126	0.000268	CcSEcCtD
Tramadol—Infestation NOS—Doxorubicin—pancreatic cancer	0.000126	0.000268	CcSEcCtD
Tramadol—Tachycardia—Docetaxel—pancreatic cancer	0.000126	0.000267	CcSEcCtD
Tramadol—Skin disorder—Docetaxel—pancreatic cancer	0.000125	0.000266	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000125	0.000265	CcSEcCtD
Tramadol—Bradycardia—Epirubicin—pancreatic cancer	0.000125	0.000264	CcSEcCtD
Tramadol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000124	0.000264	CcSEcCtD
Tramadol—Renal failure—Doxorubicin—pancreatic cancer	0.000124	0.000263	CcSEcCtD
Tramadol—Dizziness—Irinotecan—pancreatic cancer	0.000124	0.000262	CcSEcCtD
Tramadol—Haemoglobin—Epirubicin—pancreatic cancer	0.000123	0.000261	CcSEcCtD
Tramadol—Stomatitis—Doxorubicin—pancreatic cancer	0.000123	0.000261	CcSEcCtD
Tramadol—Anorexia—Docetaxel—pancreatic cancer	0.000123	0.000261	CcSEcCtD
Tramadol—Rhinitis—Epirubicin—pancreatic cancer	0.000123	0.00026	CcSEcCtD
Tramadol—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000123	0.00026	CcSEcCtD
Tramadol—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000123	0.00026	CcSEcCtD
Tramadol—Hepatitis—Epirubicin—pancreatic cancer	0.000123	0.00026	CcSEcCtD
Tramadol—Haemorrhage—Epirubicin—pancreatic cancer	0.000123	0.00026	CcSEcCtD
Tramadol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000122	0.000259	CcSEcCtD
Tramadol—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000122	0.000258	CcSEcCtD
Tramadol—Pharyngitis—Epirubicin—pancreatic cancer	0.000122	0.000258	CcSEcCtD
Tramadol—Sweating—Doxorubicin—pancreatic cancer	0.000121	0.000256	CcSEcCtD
Tramadol—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000121	0.000256	CcSEcCtD
Tramadol—Oedema peripheral—Epirubicin—pancreatic cancer	0.000121	0.000256	CcSEcCtD
Tramadol—Hypotension—Docetaxel—pancreatic cancer	0.000121	0.000255	CcSEcCtD
Tramadol—Haematuria—Doxorubicin—pancreatic cancer	0.00012	0.000255	CcSEcCtD
Tramadol—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00012	0.000255	CcSEcCtD
Tramadol—Urethral disorder—Epirubicin—pancreatic cancer	0.00012	0.000254	CcSEcCtD
Tramadol—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000119	0.000253	CcSEcCtD
Tramadol—Epistaxis—Doxorubicin—pancreatic cancer	0.000119	0.000252	CcSEcCtD
Tramadol—Vomiting—Irinotecan—pancreatic cancer	0.000119	0.000251	CcSEcCtD
Tramadol—Sinusitis—Doxorubicin—pancreatic cancer	0.000119	0.000251	CcSEcCtD
Tramadol—Dizziness—Fluorouracil—pancreatic cancer	0.000118	0.00025	CcSEcCtD
Tramadol—Visual impairment—Epirubicin—pancreatic cancer	0.000118	0.00025	CcSEcCtD
Tramadol—Rash—Irinotecan—pancreatic cancer	0.000118	0.000249	CcSEcCtD
Tramadol—Dermatitis—Irinotecan—pancreatic cancer	0.000118	0.000249	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000118	0.000249	CcSEcCtD
Tramadol—Headache—Irinotecan—pancreatic cancer	0.000117	0.000248	CcSEcCtD
Tramadol—Insomnia—Docetaxel—pancreatic cancer	0.000117	0.000247	CcSEcCtD
Tramadol—Paraesthesia—Docetaxel—pancreatic cancer	0.000116	0.000245	CcSEcCtD
Tramadol—Erythema multiforme—Epirubicin—pancreatic cancer	0.000116	0.000245	CcSEcCtD
Tramadol—Vomiting—Gemcitabine—pancreatic cancer	0.000116	0.000245	CcSEcCtD
Tramadol—Bradycardia—Doxorubicin—pancreatic cancer	0.000115	0.000244	CcSEcCtD
Tramadol—Dyspnoea—Docetaxel—pancreatic cancer	0.000115	0.000244	CcSEcCtD
Tramadol—Somnolence—Docetaxel—pancreatic cancer	0.000115	0.000243	CcSEcCtD
Tramadol—Rash—Gemcitabine—pancreatic cancer	0.000115	0.000243	CcSEcCtD
Tramadol—Dermatitis—Gemcitabine—pancreatic cancer	0.000115	0.000243	CcSEcCtD
Tramadol—Eye disorder—Epirubicin—pancreatic cancer	0.000115	0.000243	CcSEcCtD
Tramadol—Tinnitus—Epirubicin—pancreatic cancer	0.000114	0.000242	CcSEcCtD
Tramadol—Haemoglobin—Doxorubicin—pancreatic cancer	0.000114	0.000241	CcSEcCtD
Tramadol—Headache—Gemcitabine—pancreatic cancer	0.000114	0.000241	CcSEcCtD
Tramadol—Flushing—Epirubicin—pancreatic cancer	0.000114	0.000241	CcSEcCtD
Tramadol—Cardiac disorder—Epirubicin—pancreatic cancer	0.000114	0.000241	CcSEcCtD
Tramadol—Vomiting—Fluorouracil—pancreatic cancer	0.000114	0.000241	CcSEcCtD
Tramadol—Rhinitis—Doxorubicin—pancreatic cancer	0.000114	0.000241	CcSEcCtD
Tramadol—Dyspepsia—Docetaxel—pancreatic cancer	0.000114	0.000241	CcSEcCtD
Tramadol—Haemorrhage—Doxorubicin—pancreatic cancer	0.000113	0.00024	CcSEcCtD
Tramadol—Hepatitis—Doxorubicin—pancreatic cancer	0.000113	0.00024	CcSEcCtD
Tramadol—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000113	0.000239	CcSEcCtD
Tramadol—Rash—Fluorouracil—pancreatic cancer	0.000113	0.000239	CcSEcCtD
Tramadol—Dermatitis—Fluorouracil—pancreatic cancer	0.000113	0.000239	CcSEcCtD
Tramadol—Pharyngitis—Doxorubicin—pancreatic cancer	0.000113	0.000238	CcSEcCtD
Tramadol—Decreased appetite—Docetaxel—pancreatic cancer	0.000112	0.000238	CcSEcCtD
Tramadol—Headache—Fluorouracil—pancreatic cancer	0.000112	0.000237	CcSEcCtD
Tramadol—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000112	0.000237	CcSEcCtD
Tramadol—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000112	0.000237	CcSEcCtD
Tramadol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000111	0.000236	CcSEcCtD
Tramadol—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000111	0.000236	CcSEcCtD
Tramadol—Fatigue—Docetaxel—pancreatic cancer	0.000111	0.000236	CcSEcCtD
Tramadol—Angiopathy—Epirubicin—pancreatic cancer	0.000111	0.000235	CcSEcCtD
Tramadol—Urethral disorder—Doxorubicin—pancreatic cancer	0.000111	0.000235	CcSEcCtD
Tramadol—Nausea—Irinotecan—pancreatic cancer	0.000111	0.000235	CcSEcCtD
Tramadol—Immune system disorder—Epirubicin—pancreatic cancer	0.000111	0.000234	CcSEcCtD
Tramadol—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00011	0.000234	CcSEcCtD
Tramadol—Constipation—Docetaxel—pancreatic cancer	0.00011	0.000234	CcSEcCtD
Tramadol—Pain—Docetaxel—pancreatic cancer	0.00011	0.000234	CcSEcCtD
Tramadol—Chills—Epirubicin—pancreatic cancer	0.00011	0.000233	CcSEcCtD
Tramadol—Arrhythmia—Epirubicin—pancreatic cancer	0.00011	0.000232	CcSEcCtD
Tramadol—Visual impairment—Doxorubicin—pancreatic cancer	0.000109	0.000231	CcSEcCtD
Tramadol—Nausea—Gemcitabine—pancreatic cancer	0.000108	0.000229	CcSEcCtD
Tramadol—Mental disorder—Epirubicin—pancreatic cancer	0.000107	0.000227	CcSEcCtD
Tramadol—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000107	0.000227	CcSEcCtD
Tramadol—Erythema—Epirubicin—pancreatic cancer	0.000107	0.000226	CcSEcCtD
Tramadol—Malnutrition—Epirubicin—pancreatic cancer	0.000107	0.000226	CcSEcCtD
Tramadol—Feeling abnormal—Docetaxel—pancreatic cancer	0.000106	0.000225	CcSEcCtD
Tramadol—Nausea—Fluorouracil—pancreatic cancer	0.000106	0.000225	CcSEcCtD
Tramadol—Eye disorder—Doxorubicin—pancreatic cancer	0.000106	0.000224	CcSEcCtD
Tramadol—Tinnitus—Doxorubicin—pancreatic cancer	0.000106	0.000224	CcSEcCtD
Tramadol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000106	0.000224	CcSEcCtD
Tramadol—Flushing—Doxorubicin—pancreatic cancer	0.000105	0.000223	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000105	0.000223	CcSEcCtD
Tramadol—Flatulence—Epirubicin—pancreatic cancer	0.000105	0.000223	CcSEcCtD
Tramadol—Tension—Epirubicin—pancreatic cancer	0.000105	0.000222	CcSEcCtD
Tramadol—Dysgeusia—Epirubicin—pancreatic cancer	0.000104	0.000221	CcSEcCtD
Tramadol—Nervousness—Epirubicin—pancreatic cancer	0.000104	0.000219	CcSEcCtD
Tramadol—Back pain—Epirubicin—pancreatic cancer	0.000103	0.000219	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—pancreatic cancer	0.000103	0.000218	CcSEcCtD
Tramadol—Muscle spasms—Epirubicin—pancreatic cancer	0.000103	0.000217	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—pancreatic cancer	0.000102	0.000217	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000102	0.000216	CcSEcCtD
Tramadol—Abdominal pain—Docetaxel—pancreatic cancer	0.000102	0.000216	CcSEcCtD
Tramadol—Body temperature increased—Docetaxel—pancreatic cancer	0.000102	0.000216	CcSEcCtD
Tramadol—Chills—Doxorubicin—pancreatic cancer	0.000102	0.000215	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—pancreatic cancer	0.000101	0.000215	CcSEcCtD
Tramadol—Vision blurred—Epirubicin—pancreatic cancer	0.000101	0.000213	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—pancreatic cancer	9.94e-05	0.00021	CcSEcCtD
Tramadol—Ill-defined disorder—Epirubicin—pancreatic cancer	9.9e-05	0.00021	CcSEcCtD
Tramadol—Erythema—Doxorubicin—pancreatic cancer	9.87e-05	0.000209	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—pancreatic cancer	9.87e-05	0.000209	CcSEcCtD
Tramadol—Anaemia—Epirubicin—pancreatic cancer	9.86e-05	0.000209	CcSEcCtD
Tramadol—Agitation—Epirubicin—pancreatic cancer	9.81e-05	0.000208	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—pancreatic cancer	9.73e-05	0.000206	CcSEcCtD
Tramadol—Tension—Doxorubicin—pancreatic cancer	9.69e-05	0.000205	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—pancreatic cancer	9.67e-05	0.000205	CcSEcCtD
Tramadol—Malaise—Epirubicin—pancreatic cancer	9.62e-05	0.000204	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—pancreatic cancer	9.59e-05	0.000203	CcSEcCtD
Tramadol—Vertigo—Epirubicin—pancreatic cancer	9.59e-05	0.000203	CcSEcCtD
Tramadol—Syncope—Epirubicin—pancreatic cancer	9.57e-05	0.000203	CcSEcCtD
Tramadol—Back pain—Doxorubicin—pancreatic cancer	9.55e-05	0.000202	CcSEcCtD
Tramadol—Hypersensitivity—Docetaxel—pancreatic cancer	9.51e-05	0.000201	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—pancreatic cancer	9.49e-05	0.000201	CcSEcCtD
Tramadol—Palpitations—Epirubicin—pancreatic cancer	9.43e-05	0.0002	CcSEcCtD
Tramadol—Loss of consciousness—Epirubicin—pancreatic cancer	9.38e-05	0.000199	CcSEcCtD
Tramadol—Cough—Epirubicin—pancreatic cancer	9.31e-05	0.000197	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—pancreatic cancer	9.31e-05	0.000197	CcSEcCtD
Tramadol—Asthenia—Docetaxel—pancreatic cancer	9.26e-05	0.000196	CcSEcCtD
Tramadol—Convulsion—Epirubicin—pancreatic cancer	9.25e-05	0.000196	CcSEcCtD
Tramadol—Hypertension—Epirubicin—pancreatic cancer	9.21e-05	0.000195	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—pancreatic cancer	9.16e-05	0.000194	CcSEcCtD
Tramadol—Pruritus—Docetaxel—pancreatic cancer	9.14e-05	0.000193	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—pancreatic cancer	9.13e-05	0.000193	CcSEcCtD
Tramadol—Arthralgia—Epirubicin—pancreatic cancer	9.08e-05	0.000192	CcSEcCtD
Tramadol—Chest pain—Epirubicin—pancreatic cancer	9.08e-05	0.000192	CcSEcCtD
Tramadol—Myalgia—Epirubicin—pancreatic cancer	9.08e-05	0.000192	CcSEcCtD
Tramadol—Agitation—Doxorubicin—pancreatic cancer	9.07e-05	0.000192	CcSEcCtD
Tramadol—Anxiety—Epirubicin—pancreatic cancer	9.05e-05	0.000192	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	9.02e-05	0.000191	CcSEcCtD
Tramadol—Discomfort—Epirubicin—pancreatic cancer	8.98e-05	0.00019	CcSEcCtD
Tramadol—Malaise—Doxorubicin—pancreatic cancer	8.9e-05	0.000189	CcSEcCtD
Tramadol—Dry mouth—Epirubicin—pancreatic cancer	8.88e-05	0.000188	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—pancreatic cancer	8.87e-05	0.000188	CcSEcCtD
Tramadol—Syncope—Doxorubicin—pancreatic cancer	8.85e-05	0.000187	CcSEcCtD
Tramadol—Diarrhoea—Docetaxel—pancreatic cancer	8.83e-05	0.000187	CcSEcCtD
Tramadol—Confusional state—Epirubicin—pancreatic cancer	8.78e-05	0.000186	CcSEcCtD
Tramadol—Palpitations—Doxorubicin—pancreatic cancer	8.73e-05	0.000185	CcSEcCtD
Tramadol—Anaphylactic shock—Epirubicin—pancreatic cancer	8.71e-05	0.000184	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—pancreatic cancer	8.68e-05	0.000184	CcSEcCtD
Tramadol—Infection—Epirubicin—pancreatic cancer	8.65e-05	0.000183	CcSEcCtD
Tramadol—Cough—Doxorubicin—pancreatic cancer	8.62e-05	0.000182	CcSEcCtD
Tramadol—Shock—Epirubicin—pancreatic cancer	8.57e-05	0.000181	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—pancreatic cancer	8.55e-05	0.000181	CcSEcCtD
Tramadol—Nervous system disorder—Epirubicin—pancreatic cancer	8.54e-05	0.000181	CcSEcCtD
Tramadol—Dizziness—Docetaxel—pancreatic cancer	8.54e-05	0.000181	CcSEcCtD
Tramadol—Thrombocytopenia—Epirubicin—pancreatic cancer	8.53e-05	0.000181	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—pancreatic cancer	8.52e-05	0.00018	CcSEcCtD
Tramadol—Tachycardia—Epirubicin—pancreatic cancer	8.5e-05	0.00018	CcSEcCtD
Tramadol—Skin disorder—Epirubicin—pancreatic cancer	8.46e-05	0.000179	CcSEcCtD
Tramadol—Hyperhidrosis—Epirubicin—pancreatic cancer	8.42e-05	0.000178	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—pancreatic cancer	8.41e-05	0.000178	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—pancreatic cancer	8.41e-05	0.000178	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—pancreatic cancer	8.41e-05	0.000178	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—pancreatic cancer	8.38e-05	0.000177	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.35e-05	0.000177	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—pancreatic cancer	8.31e-05	0.000176	CcSEcCtD
Tramadol—Anorexia—Epirubicin—pancreatic cancer	8.3e-05	0.000176	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—pancreatic cancer	8.22e-05	0.000174	CcSEcCtD
Tramadol—Vomiting—Docetaxel—pancreatic cancer	8.21e-05	0.000174	CcSEcCtD
Tramadol—Rash—Docetaxel—pancreatic cancer	8.14e-05	0.000172	CcSEcCtD
Tramadol—Hypotension—Epirubicin—pancreatic cancer	8.14e-05	0.000172	CcSEcCtD
Tramadol—Dermatitis—Docetaxel—pancreatic cancer	8.13e-05	0.000172	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—pancreatic cancer	8.13e-05	0.000172	CcSEcCtD
Tramadol—Headache—Docetaxel—pancreatic cancer	8.09e-05	0.000171	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—pancreatic cancer	8.06e-05	0.000171	CcSEcCtD
Tramadol—Infection—Doxorubicin—pancreatic cancer	8.01e-05	0.000169	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.93e-05	0.000168	CcSEcCtD
Tramadol—Shock—Doxorubicin—pancreatic cancer	7.93e-05	0.000168	CcSEcCtD
Tramadol—Nervous system disorder—Doxorubicin—pancreatic cancer	7.9e-05	0.000167	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.89e-05	0.000167	CcSEcCtD
Tramadol—Insomnia—Epirubicin—pancreatic cancer	7.88e-05	0.000167	CcSEcCtD
Tramadol—Tachycardia—Doxorubicin—pancreatic cancer	7.86e-05	0.000167	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—pancreatic cancer	7.83e-05	0.000166	CcSEcCtD
Tramadol—Paraesthesia—Epirubicin—pancreatic cancer	7.82e-05	0.000166	CcSEcCtD
Tramadol—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.79e-05	0.000165	CcSEcCtD
Tramadol—Dyspnoea—Epirubicin—pancreatic cancer	7.76e-05	0.000164	CcSEcCtD
Tramadol—Somnolence—Epirubicin—pancreatic cancer	7.74e-05	0.000164	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—pancreatic cancer	7.68e-05	0.000163	CcSEcCtD
Tramadol—Nausea—Docetaxel—pancreatic cancer	7.67e-05	0.000162	CcSEcCtD
Tramadol—Dyspepsia—Epirubicin—pancreatic cancer	7.67e-05	0.000162	CcSEcCtD
Tramadol—Decreased appetite—Epirubicin—pancreatic cancer	7.57e-05	0.00016	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—pancreatic cancer	7.53e-05	0.000159	CcSEcCtD
Tramadol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.52e-05	0.000159	CcSEcCtD
Tramadol—Fatigue—Epirubicin—pancreatic cancer	7.51e-05	0.000159	CcSEcCtD
Tramadol—Pain—Epirubicin—pancreatic cancer	7.45e-05	0.000158	CcSEcCtD
Tramadol—Constipation—Epirubicin—pancreatic cancer	7.45e-05	0.000158	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.34e-05	0.000155	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—pancreatic cancer	7.29e-05	0.000154	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—pancreatic cancer	7.24e-05	0.000153	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—pancreatic cancer	7.18e-05	0.000152	CcSEcCtD
Tramadol—Feeling abnormal—Epirubicin—pancreatic cancer	7.18e-05	0.000152	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—pancreatic cancer	7.16e-05	0.000152	CcSEcCtD
Tramadol—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.12e-05	0.000151	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—pancreatic cancer	7.09e-05	0.00015	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—pancreatic cancer	7e-05	0.000148	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.96e-05	0.000147	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—pancreatic cancer	6.95e-05	0.000147	CcSEcCtD
Tramadol—Urticaria—Epirubicin—pancreatic cancer	6.92e-05	0.000146	CcSEcCtD
Tramadol—Constipation—Doxorubicin—pancreatic cancer	6.89e-05	0.000146	CcSEcCtD
Tramadol—Pain—Doxorubicin—pancreatic cancer	6.89e-05	0.000146	CcSEcCtD
Tramadol—Body temperature increased—Epirubicin—pancreatic cancer	6.88e-05	0.000146	CcSEcCtD
Tramadol—Abdominal pain—Epirubicin—pancreatic cancer	6.88e-05	0.000146	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—pancreatic cancer	6.64e-05	0.000141	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.59e-05	0.00014	CcSEcCtD
Tramadol—Hypersensitivity—Epirubicin—pancreatic cancer	6.42e-05	0.000136	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—pancreatic cancer	6.4e-05	0.000136	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—pancreatic cancer	6.37e-05	0.000135	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—pancreatic cancer	6.37e-05	0.000135	CcSEcCtD
Tramadol—Asthenia—Epirubicin—pancreatic cancer	6.25e-05	0.000132	CcSEcCtD
Tramadol—Pruritus—Epirubicin—pancreatic cancer	6.16e-05	0.00013	CcSEcCtD
Tramadol—Diarrhoea—Epirubicin—pancreatic cancer	5.96e-05	0.000126	CcSEcCtD
Tramadol—Hypersensitivity—Doxorubicin—pancreatic cancer	5.94e-05	0.000126	CcSEcCtD
Tramadol—Asthenia—Doxorubicin—pancreatic cancer	5.78e-05	0.000122	CcSEcCtD
Tramadol—Dizziness—Epirubicin—pancreatic cancer	5.76e-05	0.000122	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—pancreatic cancer	5.7e-05	0.000121	CcSEcCtD
Tramadol—Vomiting—Epirubicin—pancreatic cancer	5.54e-05	0.000117	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—pancreatic cancer	5.51e-05	0.000117	CcSEcCtD
Tramadol—Rash—Epirubicin—pancreatic cancer	5.49e-05	0.000116	CcSEcCtD
Tramadol—Dermatitis—Epirubicin—pancreatic cancer	5.49e-05	0.000116	CcSEcCtD
Tramadol—Headache—Epirubicin—pancreatic cancer	5.46e-05	0.000116	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—pancreatic cancer	5.33e-05	0.000113	CcSEcCtD
Tramadol—Nausea—Epirubicin—pancreatic cancer	5.17e-05	0.00011	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—pancreatic cancer	5.12e-05	0.000108	CcSEcCtD
Tramadol—Rash—Doxorubicin—pancreatic cancer	5.08e-05	0.000108	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—pancreatic cancer	5.08e-05	0.000107	CcSEcCtD
Tramadol—Headache—Doxorubicin—pancreatic cancer	5.05e-05	0.000107	CcSEcCtD
Tramadol—Nausea—Doxorubicin—pancreatic cancer	4.79e-05	0.000101	CcSEcCtD
Tramadol—OPRK1—Signaling Pathways—APOE—pancreatic cancer	2.63e-05	0.000172	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.6e-05	0.00017	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	2.58e-05	0.000169	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.57e-05	0.000168	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KDR—pancreatic cancer	2.57e-05	0.000168	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GCG—pancreatic cancer	2.57e-05	0.000168	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CD—pancreatic cancer	2.56e-05	0.000167	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.53e-05	0.000166	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	2.51e-05	0.000164	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	2.5e-05	0.000163	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GCG—pancreatic cancer	2.5e-05	0.000163	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	2.46e-05	0.000161	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.46e-05	0.000161	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	2.45e-05	0.00016	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.43e-05	0.000159	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	2.42e-05	0.000159	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—STK11—pancreatic cancer	2.41e-05	0.000158	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—TYMS—pancreatic cancer	2.41e-05	0.000158	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	2.4e-05	0.000157	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.39e-05	0.000156	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SMAD4—pancreatic cancer	2.39e-05	0.000156	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	2.38e-05	0.000156	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TERT—pancreatic cancer	2.38e-05	0.000156	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	2.38e-05	0.000155	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	2.37e-05	0.000155	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	2.37e-05	0.000155	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCL8—pancreatic cancer	2.36e-05	0.000154	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.35e-05	0.000154	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STK11—pancreatic cancer	2.35e-05	0.000153	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGF—pancreatic cancer	2.34e-05	0.000153	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HES1—pancreatic cancer	2.33e-05	0.000152	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	2.33e-05	0.000152	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	2.27e-05	0.000149	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	2.27e-05	0.000148	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CB—pancreatic cancer	2.23e-05	0.000146	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—APOE—pancreatic cancer	2.22e-05	0.000145	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	2.2e-05	0.000144	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KDR—pancreatic cancer	2.17e-05	0.000142	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	2.16e-05	0.000141	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCL8—pancreatic cancer	2.14e-05	0.00014	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.14e-05	0.00014	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.12e-05	0.000138	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.09e-05	0.000137	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	2.08e-05	0.000136	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—TYMS—pancreatic cancer	2.08e-05	0.000136	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	2.07e-05	0.000135	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	2.07e-05	0.000135	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.06e-05	0.000135	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	2.05e-05	0.000134	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	2.05e-05	0.000134	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TERT—pancreatic cancer	2.04e-05	0.000134	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	2.04e-05	0.000133	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	2.03e-05	0.000133	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HES1—pancreatic cancer	2.01e-05	0.000131	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	2e-05	0.000131	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	2e-05	0.000131	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	1.99e-05	0.00013	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGF—pancreatic cancer	1.98e-05	0.00013	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	1.98e-05	0.000129	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—APOE—pancreatic cancer	1.96e-05	0.000128	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HIF1A—pancreatic cancer	1.95e-05	0.000128	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TSC2—pancreatic cancer	1.95e-05	0.000127	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	1.92e-05	0.000126	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	1.92e-05	0.000126	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—APOE—pancreatic cancer	1.91e-05	0.000125	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	1.91e-05	0.000125	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.87e-05	0.000123	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KDR—pancreatic cancer	1.87e-05	0.000122	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CD44—pancreatic cancer	1.86e-05	0.000122	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	1.85e-05	0.000121	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	1.85e-05	0.000121	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	1.84e-05	0.00012	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.83e-05	0.000119	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	1.82e-05	0.000119	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	1.8e-05	0.000118	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	1.79e-05	0.000117	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GCG—pancreatic cancer	1.78e-05	0.000117	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NFKBIA—pancreatic cancer	1.78e-05	0.000116	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CG—pancreatic cancer	1.77e-05	0.000116	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.76e-05	0.000115	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOTCH1—pancreatic cancer	1.76e-05	0.000115	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TERT—pancreatic cancer	1.76e-05	0.000115	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	1.75e-05	0.000114	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	1.75e-05	0.000114	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.74e-05	0.000114	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	1.73e-05	0.000113	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.72e-05	0.000113	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CG—pancreatic cancer	1.72e-05	0.000113	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—NRAS—pancreatic cancer	1.72e-05	0.000113	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARG—pancreatic cancer	1.71e-05	0.000112	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGF—pancreatic cancer	1.7e-05	0.000111	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—APOE—pancreatic cancer	1.69e-05	0.00011	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	1.69e-05	0.00011	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.68e-05	0.00011	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	1.68e-05	0.00011	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—STK11—pancreatic cancer	1.68e-05	0.00011	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	1.68e-05	0.00011	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	1.67e-05	0.000109	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SRC—pancreatic cancer	1.66e-05	0.000109	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.66e-05	0.000108	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APOE—pancreatic cancer	1.64e-05	0.000107	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	1.63e-05	0.000106	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	1.62e-05	0.000106	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	1.61e-05	0.000105	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KDR—pancreatic cancer	1.61e-05	0.000105	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	1.6e-05	0.000105	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	1.6e-05	0.000104	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.58e-05	0.000104	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	1.58e-05	0.000103	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.57e-05	0.000103	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	1.57e-05	0.000103	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—pancreatic cancer	1.57e-05	0.000103	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CD—pancreatic cancer	1.56e-05	0.000102	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.53e-05	0.0001	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	1.53e-05	0.0001	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	1.53e-05	0.0001	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	1.52e-05	9.97e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	1.51e-05	9.91e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CD—pancreatic cancer	1.51e-05	9.89e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.5e-05	9.8e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—pancreatic cancer	1.49e-05	9.73e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	1.48e-05	9.7e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	1.48e-05	9.69e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	1.48e-05	9.69e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—KRAS—pancreatic cancer	1.48e-05	9.68e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.48e-05	9.65e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARG—pancreatic cancer	1.47e-05	9.62e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.47e-05	9.59e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGF—pancreatic cancer	1.46e-05	9.58e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SRC—pancreatic cancer	1.46e-05	9.52e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	1.45e-05	9.52e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.44e-05	9.44e-05	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	1.42e-05	9.32e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	1.42e-05	9.27e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	1.41e-05	9.23e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	1.4e-05	9.18e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	1.4e-05	9.16e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	1.37e-05	8.99e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	1.37e-05	8.99e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	1.36e-05	8.9e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CA—pancreatic cancer	1.36e-05	8.9e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CB—pancreatic cancer	1.36e-05	8.88e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	1.35e-05	8.83e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—pancreatic cancer	1.34e-05	8.8e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	1.34e-05	8.76e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	1.33e-05	8.73e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	1.33e-05	8.68e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CB—pancreatic cancer	1.32e-05	8.62e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—pancreatic cancer	1.3e-05	8.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	1.3e-05	8.52e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	1.3e-05	8.51e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.29e-05	8.46e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.29e-05	8.44e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	1.28e-05	8.34e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	1.27e-05	8.34e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL8—pancreatic cancer	1.27e-05	8.28e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	1.26e-05	8.26e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HRAS—pancreatic cancer	1.26e-05	8.23e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SRC—pancreatic cancer	1.23e-05	8.05e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—pancreatic cancer	1.22e-05	8e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—pancreatic cancer	1.22e-05	7.99e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CD44—pancreatic cancer	1.22e-05	7.96e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CASP3—pancreatic cancer	1.21e-05	7.93e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	1.21e-05	7.88e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	1.2e-05	7.84e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	1.19e-05	7.76e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	1.18e-05	7.74e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCND1—pancreatic cancer	1.18e-05	7.72e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—APOE—pancreatic cancer	1.17e-05	7.68e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTEN—pancreatic cancer	1.17e-05	7.67e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	1.17e-05	7.66e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	1.17e-05	7.64e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	1.17e-05	7.64e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	1.17e-05	7.64e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GCG—pancreatic cancer	1.17e-05	7.63e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—pancreatic cancer	1.16e-05	7.57e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	1.15e-05	7.49e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	1.14e-05	7.45e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	1.13e-05	7.42e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	1.11e-05	7.27e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	1.11e-05	7.24e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—pancreatic cancer	1.1e-05	7.21e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	1.1e-05	7.19e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—STK11—pancreatic cancer	1.1e-05	7.17e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	1.09e-05	7.13e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	1.08e-05	7.09e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	1.08e-05	7.05e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—pancreatic cancer	1.07e-05	7.01e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.06e-05	6.93e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SRC—pancreatic cancer	1.06e-05	6.91e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	1.05e-05	6.89e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	1.04e-05	6.83e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	1.03e-05	6.75e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	1.03e-05	6.73e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	1.02e-05	6.7e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.02e-05	6.69e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	1.02e-05	6.66e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	1.02e-05	6.66e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	1.02e-05	6.65e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	1.02e-05	6.65e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTEN—pancreatic cancer	1.01e-05	6.6e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	1.01e-05	6.58e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	9.86e-06	6.45e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	9.81e-06	6.41e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	9.57e-06	6.26e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—pancreatic cancer	9.47e-06	6.19e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	9.44e-06	6.18e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TYMS—pancreatic cancer	9.43e-06	6.17e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	9.36e-06	6.12e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	9.31e-06	6.09e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	9.26e-06	6.06e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SRC—pancreatic cancer	9.09e-06	5.95e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—pancreatic cancer	9.05e-06	5.92e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	9.04e-06	5.92e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	8.86e-06	5.79e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	8.77e-06	5.74e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	8.75e-06	5.72e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	8.75e-06	5.72e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	8.66e-06	5.66e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CA—pancreatic cancer	8.27e-06	5.41e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—pancreatic cancer	8.15e-06	5.33e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	8.13e-06	5.32e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	8.12e-06	5.31e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—pancreatic cancer	8.04e-06	5.26e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	8.04e-06	5.26e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	7.97e-06	5.21e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—pancreatic cancer	7.77e-06	5.08e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—APOE—pancreatic cancer	7.67e-06	5.02e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	7.64e-06	5e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	7.53e-06	4.93e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	7.43e-06	4.86e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	7.12e-06	4.66e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTEN—pancreatic cancer	7.01e-06	4.59e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	6.92e-06	4.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	6.92e-06	4.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—pancreatic cancer	6.76e-06	4.42e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—pancreatic cancer	6.69e-06	4.38e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARG—pancreatic cancer	6.68e-06	4.37e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	6.56e-06	4.29e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	6.4e-06	4.19e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	6.09e-06	3.98e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—pancreatic cancer	5.81e-06	3.8e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	5.65e-06	3.7e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	5.31e-06	3.47e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—pancreatic cancer	5.26e-06	3.44e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.95e-06	3.24e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTEN—pancreatic cancer	4.58e-06	3e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—pancreatic cancer	4.04e-06	2.64e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	3.23e-06	2.12e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.64e-06	1.73e-05	CbGpPWpGaD
